239 related articles for article (PubMed ID: 28032400)
21. d Rhamnose β-hederin reverses chemoresistance of breast cancer cells by regulating exosome-mediated resistance transmission.
Chen WX; Xu LY; Qian Q; He X; Peng WT; Fan WQ; Zhu YL; Tang JH; Cheng L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061173
[TBL] [Abstract][Full Text] [Related]
22. Potential roles of exosome non‑coding RNAs in cancer chemoresistance (Review).
Wang Y; Liu Q; Wang F
Oncol Rep; 2021 Feb; 45(2):439-447. PubMed ID: 33416168
[TBL] [Abstract][Full Text] [Related]
23. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
24. Exosomes in development, metastasis and drug resistance of breast cancer.
Yu DD; Wu Y; Shen HY; Lv MM; Chen WX; Zhang XH; Zhong SL; Tang JH; Zhao JH
Cancer Sci; 2015 Aug; 106(8):959-64. PubMed ID: 26052865
[TBL] [Abstract][Full Text] [Related]
25. Elevated Aurora B expression contributes to chemoresistance and poor prognosis in breast cancer.
Zhang Y; Jiang C; Li H; Lv F; Li X; Qian X; Fu L; Xu B; Guo X
Int J Clin Exp Pathol; 2015; 8(1):751-7. PubMed ID: 25755770
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of vascular endothelial growth factor release in long-term drug-treated breast cancer via transient receptor potential channel 5-Ca(2+)-hypoxia-inducible factor 1α pathway.
Zhu Y; Pan Q; Meng H; Jiang Y; Mao A; Wang T; Hua D; Yao X; Jin J; Ma X
Pharmacol Res; 2015 Mar; 93():36-42. PubMed ID: 25579062
[TBL] [Abstract][Full Text] [Related]
27. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
[TBL] [Abstract][Full Text] [Related]
28. Plasma exosome microRNAs are indicative of breast cancer.
Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin increases expression and function of transient receptor potential canonical 5 channels.
Liu Y; Xu Y; Thilo F; Friis UG; Jensen BL; Scholze A; Zheng J; Tepel M
Hypertension; 2011 Aug; 58(2):317-24. PubMed ID: 21690481
[TBL] [Abstract][Full Text] [Related]
30. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs.
Chen WX; Liu XM; Lv MM; Chen L; Zhao JH; Zhong SL; Ji MH; Hu Q; Luo Z; Wu JZ; Tang JH
PLoS One; 2014; 9(4):e95240. PubMed ID: 24740415
[TBL] [Abstract][Full Text] [Related]
31. Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.
Yang SJ; Wang DD; Li J; Xu HZ; Shen HY; Chen X; Zhou SY; Zhong SL; Zhao JH; Tang JH
Gene; 2017 Aug; 623():5-14. PubMed ID: 28438694
[TBL] [Abstract][Full Text] [Related]
32. Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation.
Han M; Gu Y; Lu P; Li J; Cao H; Li X; Qian X; Yu C; Yang Y; Yang X; Han N; Dou D; Hu J; Dong H
Mol Cancer; 2020 Feb; 19(1):26. PubMed ID: 32020881
[TBL] [Abstract][Full Text] [Related]
33. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
Shao B; Wang X; Zhang L; Li D; Liu X; Song G; Cao H; Zhu J; Li H
Technol Cancer Res Treat; 2019 Jan; 18():1533033819828709. PubMed ID: 30786836
[TBL] [Abstract][Full Text] [Related]
34. Therapy-induced chemoexosomes: Sinister small extracellular vesicles that support tumor survival and progression.
Bandari SK; Tripathi K; Rangarajan S; Sanderson RD
Cancer Lett; 2020 Nov; 493():113-119. PubMed ID: 32858103
[TBL] [Abstract][Full Text] [Related]
35. Functional Characterization of Transient Receptor Potential (TRP) Channel C5 in Female Murine Gonadotropes.
Beck A; Götz V; Qiao S; Weissgerber P; Flockerzi V; Freichel M; Boehm U
Endocrinology; 2017 Apr; 158(4):887-902. PubMed ID: 28324107
[TBL] [Abstract][Full Text] [Related]
36. Exosomes: A rising star in breast cancer (Review).
Wang L; Wang B; Wen H; Mao J; Ren Y; Yang H
Oncol Rep; 2020 Aug; 44(2):407-423. PubMed ID: 32627021
[TBL] [Abstract][Full Text] [Related]
37. Targeting PKM2 promotes chemosensitivity of breast cancer cells in vitro and in vivo.
Wang Y; Zhao H; Zhao P; Wang X
Cancer Biomark; 2021; 32(2):221-230. PubMed ID: 34092620
[TBL] [Abstract][Full Text] [Related]
38. Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer.
Zhao Y; Wei L; Liu J; Li F
Cancer Chemother Pharmacol; 2020 Jan; 85(1):77-93. PubMed ID: 31844921
[TBL] [Abstract][Full Text] [Related]
39. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes.
Zhong S; Chen X; Wang D; Zhang X; Shen H; Yang S; Lv M; Tang J; Zhao J
Oncotarget; 2016 Apr; 7(15):19601-9. PubMed ID: 26910922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
